drugset / Trial / NCT00261586

A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the Stomach

NCT00261586

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare several analgesics given in approved daily doses in combination with a daily cardioprotective dose of aspirin (81 mg), to study their bleeding properties and their effects on the stomach in healthy volunteers.

Timeline

Start
Primary completion
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1000 mg
Subject Aspirin Small molecule 81 mg
Subject Aspirin Small molecule 650 mg
Subject Celecoxib Other / unclassified 200 mg
Subject Ibuprofen Small molecule 400 mg
Subject Naproxen Small molecule 220 mg
Subject Naproxen Small molecule 440 mg
Subject rofecoxib Small molecule 25 mg

Indications

No indication recorded.